FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897358668> ?p ?o ?g. }

• W2897358668 endingPage "1347" @default.
• W2897358668 startingPage "1341" @default.
• W2897358668 abstract "Background & AimsThe risk of herpes zoster virus infection is increased among patients with inflammatory bowel diseases (IBD). The herpes zoster vaccine (HZV) is therefore recommended for these patients, but little is known about its effectiveness, resulting in low use.MethodsWe conducted a retrospective cohort study using data from the national veterans Affairs Healthcare System (VAHS) from January 1, 2000 through June 30, 2016. We collected data from 39,983 veterans with IBD who had not received the HZV by an age of 60 years. The follow-up period started at age 60 or the date of first IBD medication prescription (whichever was later) and ended with the earliest diagnosis of herpes zoster infection, the end of the study period, or date of death. We identified veterans who received the HZV during the follow-up period and compared the incidence of herpes zoster between vaccinated vs unvaccinated patients. We performed multivariable Cox regression with time-dependent analysis to determine the risk of herpes zoster associated with vaccination status in the entire cohort and stratified by IBD medication.ResultsWe identified 7170 patients who received the HZV during the follow-up period (17.9% of total cohort; 96.6% male and 94.2% Caucasian). The crude incidence rate of herpes zoster infection during the follow-up period for unvaccinated patients was 6.97/1000 person-years and for vaccinated patients was 4.09/1000 person-years. Vaccination was associated with significantly lower risk of herpes zoster infection, compared to lack of vaccination (adjusted hazard ratio, 0.54; 95% CI, 0.44 – 0.68).ConclusionVaccination was associated with a significantly reduced risk of herpes zoster infection among veterans with IBD. This vaccine is therefore effective in patients with IBD, but underused. The risk of herpes zoster virus infection is increased among patients with inflammatory bowel diseases (IBD). The herpes zoster vaccine (HZV) is therefore recommended for these patients, but little is known about its effectiveness, resulting in low use. We conducted a retrospective cohort study using data from the national veterans Affairs Healthcare System (VAHS) from January 1, 2000 through June 30, 2016. We collected data from 39,983 veterans with IBD who had not received the HZV by an age of 60 years. The follow-up period started at age 60 or the date of first IBD medication prescription (whichever was later) and ended with the earliest diagnosis of herpes zoster infection, the end of the study period, or date of death. We identified veterans who received the HZV during the follow-up period and compared the incidence of herpes zoster between vaccinated vs unvaccinated patients. We performed multivariable Cox regression with time-dependent analysis to determine the risk of herpes zoster associated with vaccination status in the entire cohort and stratified by IBD medication. We identified 7170 patients who received the HZV during the follow-up period (17.9% of total cohort; 96.6% male and 94.2% Caucasian). The crude incidence rate of herpes zoster infection during the follow-up period for unvaccinated patients was 6.97/1000 person-years and for vaccinated patients was 4.09/1000 person-years. Vaccination was associated with significantly lower risk of herpes zoster infection, compared to lack of vaccination (adjusted hazard ratio, 0.54; 95% CI, 0.44 – 0.68). Vaccination was associated with a significantly reduced risk of herpes zoster infection among veterans with IBD. This vaccine is therefore effective in patients with IBD, but underused." @default.
• W2897358668 created "2018-10-26" @default.
• W2897358668 creator A5017748759 @default.
• W2897358668 creator A5020944163 @default.
• W2897358668 creator A5025770772 @default.
• W2897358668 creator A5041936168 @default.
• W2897358668 creator A5071070019 @default.
• W2897358668 creator A5080581740 @default.
• W2897358668 date "2019-06-01" @default.
• W2897358668 modified "2023-10-06" @default.
• W2897358668 title "Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases" @default.
• W2897358668 cites W1523497330 @default.
• W2897358668 cites W1825495625 @default.
• W2897358668 cites W1981815093 @default.
• W2897358668 cites W1982821280 @default.
• W2897358668 cites W2010207831 @default.
• W2897358668 cites W2033062403 @default.
• W2897358668 cites W2035271011 @default.
• W2897358668 cites W2058409077 @default.
• W2897358668 cites W2086658590 @default.
• W2897358668 cites W2094464340 @default.
• W2897358668 cites W2106253609 @default.
• W2897358668 cites W2124600317 @default.
• W2897358668 cites W2130875526 @default.
• W2897358668 cites W2131041950 @default.
• W2897358668 cites W2131242743 @default.
• W2897358668 cites W2145593067 @default.
• W2897358668 cites W2571140916 @default.
• W2897358668 cites W2611548364 @default.
• W2897358668 cites W2749644585 @default.
• W2897358668 cites W2782178538 @default.
• W2897358668 cites W4293777482 @default.
• W2897358668 doi "https://doi.org/10.1016/j.cgh.2018.10.016" @default.
• W2897358668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30326303" @default.
• W2897358668 hasPublicationYear "2019" @default.
• W2897358668 type Work @default.
• W2897358668 sameAs 2897358668 @default.
• W2897358668 citedByCount "21" @default.
• W2897358668 countsByYear W28973586682019 @default.
• W2897358668 countsByYear W28973586682020 @default.
• W2897358668 countsByYear W28973586682021 @default.
• W2897358668 countsByYear W28973586682022 @default.
• W2897358668 countsByYear W28973586682023 @default.
• W2897358668 crossrefType "journal-article" @default.
• W2897358668 hasAuthorship W2897358668A5017748759 @default.
• W2897358668 hasAuthorship W2897358668A5020944163 @default.
• W2897358668 hasAuthorship W2897358668A5025770772 @default.
• W2897358668 hasAuthorship W2897358668A5041936168 @default.
• W2897358668 hasAuthorship W2897358668A5071070019 @default.
• W2897358668 hasAuthorship W2897358668A5080581740 @default.
• W2897358668 hasBestOaLocation W28973586681 @default.
• W2897358668 hasConcept C120665830 @default.
• W2897358668 hasConcept C121332964 @default.
• W2897358668 hasConcept C126322002 @default.
• W2897358668 hasConcept C167135981 @default.
• W2897358668 hasConcept C187212893 @default.
• W2897358668 hasConcept C201903717 @default.
• W2897358668 hasConcept C203014093 @default.
• W2897358668 hasConcept C207103383 @default.
• W2897358668 hasConcept C22070199 @default.
• W2897358668 hasConcept C2522874641 @default.
• W2897358668 hasConcept C2775969662 @default.
• W2897358668 hasConcept C2778260677 @default.
• W2897358668 hasConcept C2779001537 @default.
• W2897358668 hasConcept C2779134260 @default.
• W2897358668 hasConcept C44249647 @default.
• W2897358668 hasConcept C50382708 @default.
• W2897358668 hasConcept C61511704 @default.
• W2897358668 hasConcept C71924100 @default.
• W2897358668 hasConcept C72563966 @default.
• W2897358668 hasConceptScore W2897358668C120665830 @default.
• W2897358668 hasConceptScore W2897358668C121332964 @default.
• W2897358668 hasConceptScore W2897358668C126322002 @default.
• W2897358668 hasConceptScore W2897358668C167135981 @default.
• W2897358668 hasConceptScore W2897358668C187212893 @default.
• W2897358668 hasConceptScore W2897358668C201903717 @default.
• W2897358668 hasConceptScore W2897358668C203014093 @default.
• W2897358668 hasConceptScore W2897358668C207103383 @default.
• W2897358668 hasConceptScore W2897358668C22070199 @default.
• W2897358668 hasConceptScore W2897358668C2522874641 @default.
• W2897358668 hasConceptScore W2897358668C2775969662 @default.
• W2897358668 hasConceptScore W2897358668C2778260677 @default.
• W2897358668 hasConceptScore W2897358668C2779001537 @default.
• W2897358668 hasConceptScore W2897358668C2779134260 @default.
• W2897358668 hasConceptScore W2897358668C44249647 @default.
• W2897358668 hasConceptScore W2897358668C50382708 @default.
• W2897358668 hasConceptScore W2897358668C61511704 @default.
• W2897358668 hasConceptScore W2897358668C71924100 @default.
• W2897358668 hasConceptScore W2897358668C72563966 @default.
• W2897358668 hasIssue "7" @default.
• W2897358668 hasLocation W28973586681 @default.
• W2897358668 hasLocation W28973586682 @default.
• W2897358668 hasOpenAccess W2897358668 @default.
• W2897358668 hasPrimaryLocation W28973586681 @default.
• W2897358668 hasRelatedWork W2007928519 @default.
• W2897358668 hasRelatedWork W2017239512 @default.
• W2897358668 hasRelatedWork W2054883872 @default.
• W2897358668 hasRelatedWork W2085660659 @default.

• next